ENDRA Life Sciences
NDRA
8 hedge funds and large institutions have $1.86M invested in ENDRA Life Sciences in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
167% more funds holding
Funds holding: 3 → 8 (+5)
101% more capital invested
Capital invested by funds: $924K → $1.86M (+$936K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$1.74M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$694K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$231K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$116K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$36K |
| 2 |
IFAM
Institutional & Family Asset Management
Fort Collins,
Colorado
|
-$31K |
NDRA Hedge Fund Activity: Q4 2018 in Review
8 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2018, worth a combined $1.86M — up 101% from $924K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NDRA positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was ICM Asset Management, adding an estimated $1.74M. The largest seller was Jane Street, cutting an estimated $36K.
- 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2018, up from 3 in Q3 2018.
- Funds reported $1.86M of ENDRA Life Sciences stock for Q4 2018, up 101% quarter-over-quarter.
- 5 funds opened new ENDRA Life Sciences positions in Q4 2018 and 0 closed out, a net change of +5 holders.
- The largest ENDRA Life Sciences buyer in Q4 2018 was ICM Asset Management, an estimated $1.74M added.
- The largest ENDRA Life Sciences seller in Q4 2018 was Jane Street, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2018.